SUBJECTS : Biliary Tract Diseases | Liver Disease
LATEST MANUSCRIPTS IN Clinical and Molecular Hepatology
- Vy H Nguyen, Isaac Le, Audrey Ha, Richard Hieu Le, Nicholas Ajit Rouillard, Ashley Fong, Surya Gudapati, Jung Eun Park, Mayumi Maeda, Scott Barnett, Ramsey Cheung, Mindie H Nguyen. Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study. Clinical and molecular hepatology. 2023, 29 (4): 1002-1012
Cited : 1Read More - Ha Il Kim, Jihyun An, Seungbong Han, Ju Hyun Shim. Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis. Clinical and molecular hepatology. 2023, 29 (4): 1013-1028Cited : 3Read More
- Jeongin Yoo, Heejin Cho, Dong Ho Lee, Eun Ju Cho, Ijin Joo, Sun Kyung Jeon. Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection. Clinical and molecular hepatology. 2023, 29 (4): 1029-1042Cited : 0Read More
- Daphne J Theodorou, Stavroula J Theodorou, Ioannis V Mitselos. Letter regarding "Evidence-based hyponatremia management in liver disease". Clinical and molecular hepatology. 2023, 29 (4): 1043-1045Cited : 1Read More
- Abhijit Pratap, Umesh More, Pradnya Phalak, Anita Deshmukh. Letter regarding "Risk factors in nonalcoholic fatty liver disease". Clinical and molecular hepatology. 2023, 29 (4): 1046-1047Cited : 1Read More
- Ji Young Ryu, Seon Ha Baek, Sejoong Kim. Correspondence on Letter regarding "Evidence-based hyponatremia management in liver disease". Clinical and molecular hepatology. 2023, 29 (4): 1048-1049Cited : 0Read More
- Eileen L Yoon, Dae Won Jun. Correspondence on Letter regarding "Risk factors in nonalcoholic fatty liver disease". Clinical and molecular hepatology. 2023, 29 (4): 1050-1051Cited : 0Read More
- Qiankun Luo, Pan Liu, Yifei Dong, Tao Qin. The role of the hepatic autonomic nervous system. Clinical and molecular hepatology. 2023, 29 (4): 1052-1055Cited : 0Read More
- Gi-Ae Kim, Joon Ho Moon, Won Kim. Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity. Clinical and molecular hepatology. 2023, 29 (4): 831-843Cited : 20Read More
- Eileen L Yoon, Dae Won Jun. Waiting for the changes after the adoption of steatotic liver disease. Clinical and molecular hepatology. 2023, 29 (4): 844-850Cited : 15Read More
- Landon L Chan, Stephen L Chan. The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment. Clinical and molecular hepatology. 2023, 29 (4): 909-923Cited : 5Read More
- Ji Young Ryu, Seon Ha Baek, Sejoong Kim. Evidence-based hyponatremia management in liver disease. Clinical and molecular hepatology. 2023, 29 (4): 924-944Cited : 4Read More
- Hwa Kyung Byun, Changhwan Kim, Jinsil Seong. Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma. Clinical and molecular hepatology. 2023, 29 (4): 945-957Cited : 3Read More
- Sung Uk Lee, Tae Hyun Kim. Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma. Clinical and molecular hepatology. 2023, 29 (4): 958-968Cited : 2Read More
- Ming-Lun Yeh, Ming-Lung Yu. From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials. Clinical and molecular hepatology. 2023, 29 (4): 969-972Cited : 4Read More
